To determine whether loss of ACLY was sufficient to prevent the myofibroblast phenotype and mitigate cardiac fibrosis and functional decline in response to cardiac injury, we genetically deleted Acly exclusively in activated, post-differentiated myofibroblasts in a mouse model of pressure-overload-induced HF. This evidence concerns the gene ACLY and hydrops fetalis.